A 58-year-old woman with HFrEF (LVEF 32%) remains NYHA class II despite an ACE inhibitor and a beta-blocker at target doses. Which single addition is ...

Question

A 58-year-old woman with HFrEF (LVEF 32%) remains NYHA class II despite an ACE inhibitor and a beta-blocker at target doses. Which single addition is most appropriate now?

Accepted Answer

Mineralocorticoid receptor antagonist (e.g., spironolactone)

Answer

Ivabradine

Answer

Loop diuretic regularly

Answer

Isosorbide mononitrate

Answer

Verapamil

ukmla MCQ (SBA): Heart failure with reduced ejection fraction

A 58-year-old woman with HFrEF (LVEF 32%) remains NYHA class II despite an ACE inhibitor and a beta-blocker at target doses. Which single addition is most appropriate now?